Clinical Trials Browser

Recruiting × OTHER × Recurrence × Clear all

NCT02974647 2026-04-22

Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

Phase 2 Recruiting

Lymphoma, Recurrence

NCT03970447 2026-04-22

GBM AGILE

Phase 2/3 Recruiting

Glioblastoma, Recurrence

NCT05366179 2026-04-22

Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc

Phase 1 Recruiting

Brain Neoplasms, Glioblastoma, Recurrence

NCT06347068 2026-04-22

Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells

Phase 1 Recruiting

Breast Neoplasms, Recurrence, Triple Negative Breast Neoplasms

NCT03919240 2026-04-21

CAR-T Cell Therapy Targeting to CD19 for R/R ALL

Phase 1/2 Recruiting

LymphoidOther hematologic neoplasm

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07137494 2026-04-21

A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL)

Phase 1 Recruiting

Lymphoma, Recurrence

NCT04544592 2026-04-20

UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL

Phase 1/2 Recruiting

Burkitt Lymphoma, Recurrence, Lymphoma, B-Cell

NCT04984837 2026-04-20

Study of Lacutamab in Peripheral T-cell Lymphoma

Phase 2 Recruiting

Recurrence, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

NCT06330038 2026-04-20

GASTIVA

Phase 4 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Recurrence

NCT07340164 2026-04-20

TROY

Phase 2 Recruiting

Ovarian Neoplasms, Recurrence

NCT07540403 2026-04-20

EPOCA

Ovarian Neoplasms, Recurrence

NCT03618550 2026-04-16

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

Phase 2 Recruiting

Hodgkin Disease, Recurrence

NCT06721689 2026-04-15

PEEL-224

Phase 1/2 Recruiting

Neuroblastoma, Recurrence, Rhabdomyosarcoma

NCT07500753 2026-04-15

A Single-arm, Prospective Study of a Clad-LABU Conditioning Regimen in HSCT for R/R MDS/AML in Elderly Patients

Phase NA Recruiting

Classical hematologyOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Recurrence, Leukemia, Myeloid, Acute

NCT03483337 2026-04-14

New MRI Biomarkers in Head and Neck Cancers

Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence, Thyroid Neoplasms

NCT05996185 2026-04-14

Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma

Phase 2 Recruiting

DermatologicLymphoidOther hematologic neoplasm

Recurrence, Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT06305299 2026-04-14

Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells

Phase 1 Recruiting

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Recurrence

NCT06607692 2026-04-14

LUPARPED

Phase 1/2 Recruiting

CNSEndocrineNETSarcoma

Adrenal Cortex Neoplasms, Adrenal Gland Neoplasms, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neuroblastoma, Paraganglioma, Pheochromocytoma, Recurrence, Osteosarcoma, Sarcoma, Synovial, Esthesioneuroblastoma, Olfactory, Neuroendocrine Tumors

NCT07242963 2026-04-13

Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry Study

Medulloblastoma, Recurrence

NCT07257419 2026-04-13

CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma

Phase 1 Recruiting

LymphoidOther hematologic neoplasm

Recurrence, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07423078 2026-04-13

WOLF

Phase 2 Recruiting

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence

NCT05010005 2026-04-09

A Study of Ruxolitinib and Duvelisib in People With Lymphoma

Phase 1 Recruiting

LymphoidOther hematologic neoplasm

Recurrence, Leukemia, Prolymphocytic, T-Cell, Lymphoma, T-Cell, Leukemia, Large Granular Lymphocytic

NCT05852717 2026-04-08

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

Phase 2 Recruiting

Neoplasms, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT06007937 2026-04-08

A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer

Phase 1/2 Recruiting

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Recurrence

NCT06713837 2026-04-08

IMPACT-AML

Phase 3 Recruiting

Other hematologic neoplasm

Disease, Recurrence, Leukemia, Myeloid, Acute

NCT07511426 2026-04-06

U96-CAR-T-Cells For R/R B-ALL

Phase 1 Recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Recurrence, Leukemia, B-Cell

NCT05544968 2026-04-03

Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies

Phase 1 Recruiting

LymphoidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Lymphoma, Neoplasms, Recurrence, Lymphoma, Large-Cell, Anaplastic

NCT06660368 2026-04-01

BCL2i CLAG-M in R/R Acute Myeloid Leukemia

Phase 2 Recruiting

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

NCT07420517 2026-03-30

DutaBCa-1

Phase 2 Recruiting

Urinary Bladder Neoplasms, Recurrence

NCT07501650 2026-03-30

Pembrolizumab Plus Ultrasound-Induced Microbubble Cavitation in Head and Neck Cancer

Phase 1 Recruiting

Head and Neck Neoplasms, Recurrence

NCT05184816 2026-03-27

A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis

Phase 1 Recruiting

Recurrence, Meningeal Carcinomatosis

NCT07113691 2026-03-27

TIARA

Phase 1 Recruiting

Recurrence

NCT07494201 2026-03-27

MIMICC

Phase NA Recruiting

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Recurrence, Colorectal Neoplasms, Anastomotic Leak

NCT05328505 2026-03-24

MIDAS-Prostate

Phase NA Recruiting

Adenocarcinoma, Prostatic Neoplasms, Recurrence

NCT07489989 2026-03-24

Enhancing CAR-T Cell Therapy Efficacy in B-cell Lymphoma Via Chidamide and PD-1 Inhibitor Combination.

Phase 2 Recruiting

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT00599092 2026-03-23

Pituitary Tumor Surveillance: Pathogenic Correlation

Pituitary Neoplasms, Recurrence

NCT05669846 2026-03-23

Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT07485296 2026-03-20

POST-BIO

Phase 2 Recruiting

Squamous Cell Carcinoma of Head and Neck, Recurrence

NCT06158139 2026-03-19

Autologous CAR-T Cells Targeting B7-H3 in PDAC

Phase 1 Recruiting

Gastrointestinal

Pancreatic Neoplasms, Recurrence

NCT06725173 2026-03-18

Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.

Other solid neoplasm

Recurrence, Retinoblastoma

NCT07209449 2026-03-18

A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer

Phase 2 Recruiting

Recurrence, Endometrial Neoplasms

NCT07164560 2026-03-17

Exploratory Study of Umbilical Cord Blood-Derived CAR-NK Cell Therapy Targeting TRBC1/2 for Relapsed/Refractory T-Cell Lymphoma

Phase 1 Recruiting

Recurrence, Lymphoma, T-Cell, Peripheral

NCT07472972 2026-03-16

Dynamic Individualized Risk Profiling of Patients With Relapsed/Refractory Lymphoid Malignancies and CD19-CAR T Cell Therapy (INTeRCePT 2.0)

Lymphoma, Recurrence

NCT05292664 2026-03-12

Venetoclax Basket Trial for High Risk Hematologic Malignancies

Phase 1 Recruiting

LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Neoplasm Metastasis, Recurrence, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06832865 2026-03-12

ELISA in Relapsed/Refractory MM

Phase 2 Recruiting

Multiple Myeloma, Recurrence

NCT05607108 2026-03-11

A Study of ZEN003694 in People With Squamous Cell Lung Cancer

Phase 2 Recruiting

Neoplasm Metastasis, Recurrence

NCT05748197 2026-03-10

A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia

Phase 1 Recruiting

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

NCT06459024 2026-03-10

IMPACT STREAM

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

NCT07460362 2026-03-10

Glofitamab Combined With Lenalidomide in High Risk Patients With Relapsed or Refractory Mantle Cell Lymphoma

Phase 2 Recruiting

Recurrence, Lymphoma, Mantle-Cell

NCT06321484 2026-03-04

Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer

Phase 1 Recruiting

Ovarian Neoplasms, Recurrence